About Invicro
Invicro is a Healthcare company based in Boston (United States) founded in 2008, and was acquired by Calyx in March 2024. Provide contract research imaging services and software. Invicro has raised $45.84 million across 3 funding rounds from investors including Konica Minolta, Calyx and HHS. The company has 308 employees. Invicro has completed 2 acquisitions, including Imanova and Molecular NeuroImaging. Invicro offers products and services including Imaging Core Lab, eClinical RTSM, Preclinical Imaging, Clinical Adjudication, and Radiochemistry. Its focus areas include HealthTech, Clinical Labs IT, Radiology and Image Analysis. Its competitors include Subtle Medical and Cleerly; 2 of its 2 listed competitors have raised funding.
Company details
Invicro was founded in 2008 and is headquartered in Boston, United States. Contract research organization services in medical imaging are offered to pharmaceutical and biotechnology companies throughout the drug development process. Coverage includes all imaging modalities and therapeutic areas such as neurology, oncology, systemic diseases, and rare conditions. Software platforms like VivoQuant, iPACS, and the IQ-Analytics suitewith tools including AmyloidIQ, TauIQ, and DaTIQare also provided for informatics support.
- Headquarters Boston, United States
- Employees 308
- Stage Acquired
- SectorsHealthcare
- Website invicro.com
- Social LinkedIn
- Acquired by Konica Minolta (Sep 2017)
- Total Equity Funding$45.84M (USD)
in 3 rounds
- Latest Funding Round$394K (USD), Grant
Jun 2016
- InvestorsKonica Minolta
& 2 more
- Employee Count308
- Investments & AcquisitionsImanova
& 1 more
- Acquired by
Products & Services of Invicro
Invicro offers a comprehensive portfolio of products and services, including Imaging Core Lab, eClinical RTSM, Preclinical Imaging, Clinical Adjudication, and Radiochemistry.
Delivers high-quality imaging data for global clinical trials
Manages randomization and supply for efficient clinical studies
Supports imaging study designs in pharmaceutical development
Reviews trial event assessments for accurate outcomes
Radiolabels agents to aid in therapeutic research
Funding Insights of Invicro
Invicro has successfully raised a total of $45.84M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $394 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45.84M
- Total Rounds 3
- Last Round Grant — $394,005
- First Round $1.94M
(May 2012)
- Investors Count 1
All 3 funding rounds of Invicro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $394,005 | Grant | – | – | – |
| Feb 2016 | $45.84M | Series B | – | – | – |
| May 2012 | $1.94M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Invicro
Invicro has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Konica Minolta, Calyx and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRO providing imaging services for clinical development | 2019 | calyx.ai | Nottingham, United Kingdom | |
Konica Minolta is engaged in providing imaging and printing solutions. | 1873 | konicaminolta.com | Tokyo, Japan | |
| hhs.gov |
Investor details for Invicro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Invicro
21 people are tracked at Invicro (11 in leadership, 2 in board & advisors, 8 in team); the tracked headcount is 308.
| Name | Role | Group |
|---|---|---|
Eugenii Rabiner | EVP & Head, Translational Applications | Leadership |
Timothy Moran | Senior Director, Product Management | Leadership |
Nicole Hasty | Director, Legal Affairs | Leadership |
Benjamin Murphy | VP, Finance | Leadership |
Deb Lenhart | Director, Clinical Data Management | Leadership |
Cristian C C. | Associate Director, Translational Research | Leadership |
Eli White | VP Of Engineering | Leadership |
Paul Labas | Senior Director, Technical Quality And Systems Compliance | Leadership |
Sade Iriah | Imaging Scientist 1 - Study Director Of Discovery Research And Nuclear Medicine | Leadership |
Sarah Yancy | Senior Human Resources Business Partner | Leadership |
David Strinati | Director Business Development | Leadership |
Kenneth Marek | Scientific & Medical Advisor | Board & advisors |
John Seibyl | Scientific & Medical Advisor | Board & advisors |
Nigel Hickey | Facilities Manager | Team |
Christine Sandiego | Senior Scientist | Team |
Joshua Lovins | Inside Sales Manager | Team |
Dipti Patel | Senior Associate Scientist | Team |
Jane Bartosik | Senior Imaging Center Set Up Specialist | Team |
Dennis Nguyen | Senior IT Professional | Team |
Jesse Waukau | Principal Financial Analyst | Team |
1 more people are available in the full profile.
Complete people profiles for Invicro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invicro
Invicro has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Imanova and Molecular NeuroImaging.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
PET and MRI imaging services for drug development are provided. | imanova.co.uk | London, United Kingdom | 2011 | Sep 2017 | •••• | |
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders | mnimaging.com | New Haven, United States | 2000 | Feb 2016 | •••• |
Complete acquisition details for Invicro
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Invicro
7 dated milestones of Invicro across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Invicro is founded.
- Funding First funding round of $1.9M.
- Acquisition Acquires Molecular NeuroImaging.
- Funding Latest funding round, Grant, of $394K.
- Acquisition Acquires Imanova.
- Exit Acquired by Konica Minolta.
- Exit Acquired by Calyx.
Competitors of Invicro
Invicro has 2 listed competitors in our database, 2 of them funded. They include Subtle Medical and Cleerly.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| subtlemedical.com | 2017 | Palo Alto, United States | $18.3M | 23 | AI-driven solutions for medical diagnostic imaging are developed. | |
| cleerlyhealth.com | 2016 | Denver, United States | $578.48M | Atherosclerotic plaque is quantified by AI using coronary CT angiograms. |
Detailed competitors of Invicro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Invicro
Websites that share an audience with Invicro (invicro.com).
Websites whose visitors overlap most with Invicro. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| inventivhealthclinical.com | 100% | View details | |||
| perceptive.com | 99% | 23.9K | #1,274,521 | View details | |
beta.jackimaging.com | beta.jackimaging.com | 80% | – | ||
| mimsoftware.com | 61% | 53.7K | #472,553 | View details | |
site.danestreet.com | site.danestreet.com | 61% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Invicro
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Invicro (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Invicro
Complete news archive for Invicro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invicro
Invicro was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Invicro is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Invicro is a funded company, having raised a total of $45.84M across 3 funding rounds to date. The company's 1st funding round was a Grant of $1.94M, raised on May 2012.
Invicro has 308 employees.
Invicro was founded in 2008 and is headquartered in Boston, United States. Contract research organization services in medical imaging are offered to pharmaceutical and biotechnology companies throughout the drug development process. Coverage includes all imaging modalities and therapeutic areas such as neurology, oncology, systemic diseases, and rare conditions. Software platforms like VivoQuant, iPACS, and the IQ-Analytics suitewith tools including AmyloidIQ, TauIQ, and DaTIQare also provided for informatics support.
Invicro's top competitors include Subtle Medical and Cleerly.
Invicro offers Imaging Core Lab, eClinical RTSM, Preclinical Imaging, Clinical Adjudication, and Radiochemistry.
Invicro has made 2 acquisitions, including Imanova, and Molecular NeuroImaging.
Invicro has 3 investors. Key investors include Konica Minolta, Calyx, and HHS.
Yes. Invicro was acquired by Konica Minolta in September 2017.